RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
RT @obogler: PubMed #malebreastcancer Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. https://t.co/…
RT @malefitness: Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #maleb…
Tamox-treated patients have similar survival rates, whereas AI treatment is associated with poorer survival in men. #malebreastcancer #bcsm https://t.co/LNY5WaC846
PubMed #malebreastcancer Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. https://t.co/H0iKQiT141